Risk factors for significant liver fibrosis in genotype D HBeAg-negative chronic hepatitis B infection with persistently normal ALT and high serum HBVDNA levels: 1039
- Authors:
- AC Ormeci, F Akyuz, B Baran, OM Soyer, S Gokturk, C Karaca, ...
- Journal:
- Hepatology 58, 709A
- Publication Year:
- 2013
- Citations:
- 1
- Subject Area:
- Viral Hepatitler
No verified DOI was found for this publication. The Google Scholar record is shown as the source.
Other Publications in This Subject Area
- The association with histopathological findings and predictive significance of transforming growth factor beta 1 (TGF Β1) in patients with chronic viral hepatitis (2023)
- Can Interferon Therapy Change the Natural Course of Hepatitis Delta Infection?: a Clinical and Pathological Study (2022)
- OĞUZ KAĞAN BAKKALOĞLU (2022)
- Evaluation of safety and efficacy of tenofovir disoproxil in hemodialysis and renal transplant patients monoinfected with hepatitis B virus based on real life data (2022)
- Changing epidemiology of chronic hepatitis C: patients are older and at a more advanced stage at the time of diagnosis (2019)
This list was extracted from Prof. Dr. Çetin Karaca's public Google Scholar profile; DOI matches were verified against CrossRef. Citation counts reflect Google Scholar's data at extraction time and are not updated in real time.
← Back to Viral Hepatitler publications